Application of nano-radiosensitizers in combination cancer therapy

Mohammad Varzandeh, Leila Sabouri, Vahid Mansouri, Maliheh Gharibshahian, Nima Beheshtizadeh, Michael R. Hamblin, Nima Rezaei

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)


Radiosensitizers are compounds or nanostructures, which can improve the efficiency of ionizing radiation to kill cells. Radiosensitization increases the susceptibility of cancer cells to radiation-induced killing, while simultaneously reducing the potentially damaging effect on the cellular structure and function of the surrounding healthy tissues. Therefore, radiosensitizers are therapeutic agents used to boost the effectiveness of radiation treatment. The complexity and heterogeneity of cancer, and the multifactorial nature of its pathophysiology has led to many approaches to treatment. The effectiveness of each approach has been proven to some extent, but no definitive treatment to eradicate cancer has been discovered. The current review discusses a broad range of nano-radiosensitizers, summarizing possible combinations of radiosensitizing NPs with several other types of cancer therapy options, focusing on the benefits and drawbacks, challenges, and future prospects.

Original languageEnglish
Article numbere10498
JournalBioengineering and Translational Medicine
Issue number3
Publication statusPublished - May 2023


  • cancer treatment
  • combination therapy
  • high-z nanoparticles
  • oxygen-mimetics
  • radiosensitizers

ASJC Scopus subject areas

  • Biotechnology
  • Biomedical Engineering
  • Pharmaceutical Science


Dive into the research topics of 'Application of nano-radiosensitizers in combination cancer therapy'. Together they form a unique fingerprint.

Cite this